Kimberly McCollum
Women's Health · Bulverde, TXNPI 1922684364
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 146 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 20 manufacturers reported payments, led by Novo Nordisk at 28.9% of the total. Among women's health clinicians in TX with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 146 payments — averaging $17.53 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Novo Nordisk$740
- AbbVie$380
- Lilly USA, LLC$321
- Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$289
- Pfizer$166
- Astellas Pharma US Inc$153
- plus $510 from 14 others
What the payments were for
- Food & beverage$2,560100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Novo Nordisk | 45 | $740 |
| AbbVie | 19 | $380 |
| Lilly USA, LLC | 17 | $321 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 22 | $289 |
| Pfizer | 9 | $166 |
| Astellas Pharma US Inc | 3 | $153 |
| Currax Pharmaceuticals LLC | 8 | $121 |
| Mayne Pharma Commercial LLC | 5 | $55 |
| Biohaven Pharmaceutical Holding Company Ltd. | 2 | $55 |
| Millicent US Inc | 3 | $47 |
| Acella Pharmaceuticals, LLC | 2 | $42 |
| Halozyme Inc | 2 | $37 |
| IBSA Pharma Inc. | 2 | $32 |
| Axsome Therapeutics, Inc. | 1 | $29 |
| Antares Pharma, Inc. | 1 | $21 |
| Amneal Pharmaceuticals LLC | 1 | $17 |
| Therapeuticsmd, Inc. | 1 | $16 |
| Amgen | 1 | $13 |
| Avion Pharmaceuticals | 1 | $13 |
| QOL Medical, LLC | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$2,560 in reported general payments places this provider in the 90th percentile of 609 women's health providers in Texas.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| ProgesteroneProgesterone, Micronized | 137 | $5,356 |
| Liothyronine Sodium | 43 | $1,193 |
| Estradiol | 46 | $470 |
| Spironolactone | 38 | $355 |
| Ropinirole Hcl | 11 | $111 |
| Metformin Hcl ErMetformin Hcl | 16 | $61 |
Paid to pharmacies, not to this prescriber.
Other women's health in Bulverde
- Evelyn TingGrapevine$89K
- Christina TrumanWaco$70K
- Kayla CastanedaEl Paso$53K
- Shelagh LarsonFort Worth$43K
- Amanda ArmondAustin$17K
- Joann St PierreHouston$15K
- Christina BlancoEl Paso$14K
- Ricshonda MilburnGalveston$13K
- Sandra EastlingLubbock$12K
- Lori WinkHouston$9K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.